June 23rd, 2025 “EURETINA-Brief”© Issue No. 319
Dear EURETINA Members, A very warm welcome to the June 23rd, 2025 edition of EURETINA’s web-based digital periodical, “EURETINA Brief”. EURETINA are delighted to continue…
EURETINA’s
DIGITAL
NEWSLETTER
Featured Articles
1
June 23rd, 2025
Latest News
June 23rd, 2025 “EURETINA-Brief”© Issue No. 319
Dear EURETINA Members, A very warm welcome to the June 23rd, 2025 edition of EURETINA’s…
First genome-wide association study (GWAS) on reticular pseudodrusen (RPD) provides a clear relationship between RPD and the ARMS2-HTRA1 locus.
Researchers based in Moorfields Eye Hospital, NHS Foundation Trust, London, have presented the first genome-wide…
Swedish clinical study reports a 3% increased risk of stroke within 90 days of anti-VEGF treatments.
An independent study, funded by the Swedish government, has reported that intravitreal injections of anti-VEGF…
VeonGen Therapeutics GmbH announce re-branding of the company (previously ViGeneron) and the progression of treatments for Stargardt’s disease and retinitis pigmentosa.
VeonGen Therapeutics GmbH, based in Munich, Germany, have announced the progression of two proprietary gene…